Blood transcript analysis and metastatic recurrent small bowel carcinoid management

BACKGROUND: Detection of neuroendocrine tumor (NET) disease progression is a key issue in determining management. Currently, assessment is by imaging (MRI/CT and Octreoscan®) and plasma Chromogranin A (CgA) measurement. CASE PRESENTATION: We report use of a NET-specific multigene PCR-derived blood t...

Descripción completa

Detalles Bibliográficos
Autores principales: Modlin, Irvin M, Drozdov, Ignat, Bodei, Lisa, Kidd, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148943/
https://www.ncbi.nlm.nih.gov/pubmed/25095873
http://dx.doi.org/10.1186/1471-2407-14-564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148943/
https://www.ncbi.nlm.nih.gov/pubmed/25095873
http://dx.doi.org/10.1186/1471-2407-14-564

Ejemplares similares